# Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma

> **NCT04673266** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 11 (actual)

## Conditions studied

- Lymphoma Patients
- Thrombocytopenia

## Interventions

- **DRUG:** Romiplostim

## Key facts

- **NCT ID:** NCT04673266
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-14
- **Primary completion:** 2026-04-07
- **Final completion:** 2026-04-07
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04673266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04673266, "Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04673266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*